These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30289975)

  • 1. The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk.
    MacKintosh ML; Derbyshire AE; McVey RJ; Bolton J; Nickkho-Amiry M; Higgins CL; Kamieniorz M; Pemberton PW; Kirmani BH; Ahmed B; Syed AA; Ammori BJ; Renehan AG; Kitchener HC; Crosbie EJ
    Int J Cancer; 2019 Feb; 144(3):641-650. PubMed ID: 30289975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women at extreme risk for obesity-related carcinogenesis: Baseline endometrial pathology and impact of bariatric surgery on weight, metabolic profiles and quality of life.
    Modesitt SC; Hallowell PT; Slack-Davis JK; Michalek RD; Atkins KA; Kelley SL; Arapovic S; Shupnik MA; Hoehn K
    Gynecol Oncol; 2015 Aug; 138(2):238-45. PubMed ID: 26013696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study.
    Derbyshire AE; Allen JL; Gittins M; Lakhiani B; Bolton J; Shaw J; Pemberton PW; Needham M; MacKintosh ML; Edmondson RJ; Kitchener HC; Crosbie EJ
    Cancer Prev Res (Phila); 2021 Feb; 14(2):263-274. PubMed ID: 32998940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The Endometrium.
    Barr CE; Ryan NAJ; Derbyshire AE; Wan YL; MacKintosh ML; McVey RJ; Bolton J; Fitzgerald C; Awad D; Slade RJ; Syed AA; Ammori BJ; Crosbie EJ
    Cancer Prev Res (Phila); 2021 Nov; 14(11):1041-1050. PubMed ID: 34348914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight loss.
    Linkov F; Goughnour SL; Ma T; Xu Z; Edwards RP; Lokshin AE; Ramanathan RC; Hamad GG; McCloskey C; Bovbjerg DH
    Gynecol Oncol; 2017 Oct; 147(1):133-138. PubMed ID: 28797697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of obesity and bariatric surgery on the immune microenvironment of the endometrium.
    Naqvi A; MacKintosh ML; Derbyshire AE; Tsakiroglou AM; Walker TDJ; McVey RJ; Bolton J; Fergie M; Bagley S; Ashton G; Pemberton PW; Syed AA; Ammori BJ; Byers R; Crosbie EJ
    Int J Obes (Lond); 2022 Mar; 46(3):605-612. PubMed ID: 34857870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bariatric surgery-induced weight loss changes immune markers in the endometrium of morbidly obese women.
    Linkov F; Elishaev E; Gloyeske N; Edwards R; Althouse AD; Geller MA; Svendsen C; Argenta PA
    Surg Obes Relat Dis; 2014; 10(5):921-6. PubMed ID: 25439003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery.
    Argenta P; Svendsen C; Elishaev E; Gloyeske N; Geller MA; Edwards RP; Linkov F
    Gynecol Oncol; 2014 Apr; 133(1):78-82. PubMed ID: 24680595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study.
    Kokkinos A; Liaskos C; Alexiadou K; Papassotiriou I; Margeli A; Argyrakopoulou G; Perrea D; Alexandrou A; Katsilambros N; Diamantis T; Tentolouris N
    J Endocrinol Invest; 2021 Mar; 44(3):599-608. PubMed ID: 32681464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity surgery and risk of cancer.
    Mackenzie H; Markar SR; Askari A; Faiz O; Hull M; Purkayastha S; Møller H; Lagergren J
    Br J Surg; 2018 Nov; 105(12):1650-1657. PubMed ID: 30003539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bariatric surgery and endometrial pathology in asymptomatic morbidly obese women: a prospective, pilot study.
    Argenta PA; Kassing M; Truskinovsky AM; Svendsen CA
    BJOG; 2013 Jun; 120(7):795-800. PubMed ID: 23231632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study.
    Wang Y; Zhou R; Zhang X; Liu H; Shen D; Wang J
    BMC Womens Health; 2021 Jun; 21(1):252. PubMed ID: 34162378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome and endometrial hyperplasia: an overview of the role of bariatric surgery in female fertility.
    Charalampakis V; Tahrani AA; Helmy A; Gupta JK; Singhal R
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():220-226. PubMed ID: 27773356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer.
    Yates MS; Coletta AM; Zhang Q; Schmandt RE; Medepalli M; Nebgen D; Soletsky B; Milbourne A; Levy E; Fellman B; Urbauer D; Yuan Y; Broaddus RR; Basen-Engquist K; Lu K
    Cancer Prev Res (Phila); 2018 Aug; 11(8):477-490. PubMed ID: 29716897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial cancer and bariatric surgery: A scoping review.
    Aubrey C; Black K; Campbell S; Pin S
    Surg Obes Relat Dis; 2019 Mar; 15(3):497-501. PubMed ID: 30700395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort.
    Dottino JA; Zhang Q; Loose DS; Fellman B; Melendez BD; Borthwick MS; McKenzie LJ; Yuan Y; Yang RK; Broaddus RR; Lu KH; Soliman PT; Yates MS
    Am J Obstet Gynecol; 2021 Mar; 224(3):278.e1-278.e14. PubMed ID: 32835719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of bariatric surgery in people with endometrial cancer and atypical hyperplasia: A qualitative study.
    Kim SR; Ene GEV; Simpson A; Gesink D; Ferguson SE
    Gynecol Oncol; 2023 Feb; 169():12-16. PubMed ID: 36463795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Referring survivors of endometrial cancer and complex atypical hyperplasia to bariatric specialists: a prospective cohort study.
    Jernigan AM; Maurer KA; Cooper K; Schauer PR; Rose PG; Michener CM
    Am J Obstet Gynecol; 2015 Sep; 213(3):350.e1-10. PubMed ID: 25981846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial histology in severely obese bariatric surgery candidates: an exploratory analysis.
    Kaiyrlykyzy A; Freese KE; Elishaev E; Bovbjerg DH; Ramanathan R; Hamad GG; McCloskey C; Althouse AD; Huang M; Edwards RP; Linkov F
    Surg Obes Relat Dis; 2015; 11(3):653-8. PubMed ID: 25820079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.